...
首页> 外文期刊>Journal of cataract and refractive surgery >Randomized comparison of postoperative use of hydrogel ocular bandage and collagen corneal shield for wound protection and patient tolerability after cataract surgery.
【24h】

Randomized comparison of postoperative use of hydrogel ocular bandage and collagen corneal shield for wound protection and patient tolerability after cataract surgery.

机译:白内障手术后水凝胶眼创可贴和胶原蛋白角膜防护罩在伤口保护和患者耐受性方面的随机比较。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To compare the safety and efficacy of a hydrogel bandage and a collagen corneal shield in providing wound protection and relief of pain/discomfort in the acute period after uneventful unilateral clear corneal phacoemulsification cataract surgery with foldable intraocular lens (IOL) implantation. SETTING: Seventeen investigational sites in the United States. DESIGN: Prospective randomized single-masked parallel study. METHODS: The study comprised patients scheduled to have unilateral clear corneal cataract surgery with posterior chamber intraocular lens implantation. The patients were examined preoperatively and frequently for 30 days postoperatively. The design was a noninferiority study of the 2 primary endpoints, device performance and maximum reported postoperative pain. RESULTS: The device performance success was 78.6% (228/290) for the hydrogel bandage and 26.5% (26/98) for the corneal shield (P<.0001 for noninferiority). Analyses indicated that the hydrogel bandage was superior to the corneal shield in device performance (P<.001; difference = 52.1%; 95% confidence interval, 41.6%-61.4%). The maximum postoperative pain/discomfort score of the hydrogel bandage (mean 1.3 +/- 1.8 [SD]; scale 0 to 10) was noninferior to that of the corneal shield (1.1 +/- 1.6) in the first 4 hours after surgery (P<.001). Adverse events in the cataract surgeries were reported in 22.2% (70/316) and 36.5% (38/104) of hydrogel bandage patients and corneal shield patients, respectively (P = .0045). CONCLUSION: The hydrogel bandage was safe and effective for ocular surface protection and relief of pain/discomfort when applied topically to clear corneal incisions used in cataract or IOL implantation surgery. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned. Additional disclosures are found in the footnotes.
机译:目的:比较水凝胶绷带和胶原蛋白角膜防护罩在无创单侧透明角膜超声乳化白内障手术联合可折叠人工晶状体植入术后的急性期提供伤口保护和缓解疼痛/不适的安全性和有效性。地点:美国的17个研究地点。设计:前瞻性随机单掩蔽平行研究。方法:该研究包括计划进行后房人工晶状体植入的单侧透明角膜白内障手术的患者。术前对患者进行了检查,并在术后30天进行了频繁检查。该设计是一项对2个主要终点,设备性能和最大报道的术后疼痛的非劣效性研究。结果:水凝胶绷带的器械性能成功率为78.6%(228/290),角膜防护罩的器械性能成功率为26.5%(26/98)(非劣效性为P <.0001)。分析表明,水凝胶绷带在装置性能方面优于角膜防护罩(P <.001;差异= 52.1%; 95%置信区间,41.6%-61.4%)。在手术后的最初4小时内,水凝胶绷带的最大术后疼痛/不适评分(平均值1.3 +/- 1.8 [SD];等级0至10)不逊于角膜防护罩(1.1 +/- 1.6)( P <.001)。分别有22.2%(70/316)和36.5%(38/104)的水凝胶绷带患者和角膜防护患者发生白内障手术不良事件(P = .0045)。结论:水凝胶绷带局部应用在白内障或人工晶状体植入手术中清除角膜切口时,可安全有效地保护眼表和减轻疼痛/不适。财务披露:没有任何作者对所提及的任何材料或方法有财务或所有权利益。在脚注中可以找到其他披露内容。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号